A meta-analysis of associations of IL-10 gene polymorphisms with acute leukemia susceptibility

被引:1
作者
Fan, Yu-Xin [1 ]
Chen, Li -Rong [2 ]
Gan, Run-Xin [3 ]
Yin, Sun-Jun [2 ]
Wang, Ping [2 ]
Meng, Rui [2 ]
Huang, Yan-Hua [2 ]
Jiang, Fang-Fang [2 ]
He, Gong-Hao [2 ]
机构
[1] Yunnan Univ Chinese Med, Res Ctr Clin Pharmacol, Affiliated Hosp 1, Kunming, Peoples R China
[2] 920th Hosp Joint Logist Support Force Peoples Libe, Dept Clin Pharm, Kunming, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Reprod Med Ctr, Changsha, Peoples R China
关键词
Interleukin-10; Acute leukemia; Single nucleotide polymorphisms; Susceptibility; Meta; -analysis; ACUTE LYMPHOBLASTIC-LEUKEMIA; TUMOR-NECROSIS-FACTOR; PROMOTER POLYMORPHISMS; INTERLEUKIN-10; TRANSCRIPTION; TNF-ALPHA; RISK; EXPRESSION; HAPLOTYPES; VARIANTS; CANCER;
D O I
10.1016/j.cyto.2023.156312
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Recently, increasing evidence has demonstrated that IL-10 single nucleotide polymorphisms (SNPs) are associated with the risk of acute leukemia (AL), but the findings of different articles remain controversial. Thus, we performed a meta-analysis to further investigate the exact roles of IL-10 SNPs in AL susceptibility. Methods: Six common Chinese and English databases were utilized to retrieve eligible studies. The strength of the association was assessed by calculating odds ratios and 95 % confidence intervals. All analyses were carried out using Review Manager (version 5.3) and STATA (version 15.1). The registered number of this research is CRD42022373362. Results: A total of 6391 participants were enrolled in this research. The results showed that the AG genotype of rs1800896 increased AL risk in the heterozygous codominant model (AG vs. AA, OR = 1.41, 95 % CI = 1.04-1.92, P = 0.03) and overdominant model (AG vs. AA + GG, OR = 1.32, 95 % CI = 1.04-1.70, P = 0.03). In the subgroup analysis, associations between the G allele, GG genotype, AG genotype, AG + GG genotype of rs1800896 and increased AL risk were also observed in the mixed population based on allelic, homozygote codominant, heterozygous codominant, dominant, and overdominant models. Furthermore, an association between the AC genotype of rs1800872 and increased AL risk was observed in the Caucasian population in the overdominant model. However, the rs1800871, rs3024489 and rs3024493 polymorphisms did not affect AL risk. Conclusion: IL-10 rs1800896 and rs1800872 affected the susceptibility of AL and therefore may be biomarkers for early screening and risk prediction of AL.
引用
收藏
页数:12
相关论文
共 59 条
  • [1] IL-10 rs1800896 Polymorphism: A Risk Factor for Adult Acute Lymphoblastic Leukemia
    Abdalhabib, Ezeldine K.
    Alzahrani, Badr
    Saboor, Muhammad
    Hamza, Alneil
    Elfaki, Elyasa M.
    Alanazi, Fehaid
    Alenazy, Fawaz O.
    Algarni, Abdulrahman
    Ibrahim, Ibrahim Khider
    Mohamed, Hozifa A.
    Alfeel, Ayman Hussein
    Alshaikh, Nahla Ali
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2022, 15 : 809 - 815
  • [2] Comparison study for identifying promoter allelic polymorphism in interleukin 10 and tumor necrosis factor α genes
    Agarwal, P
    Oldenburg, MC
    Czarneski, JE
    Morse, RM
    Hameed, MR
    Cohen, S
    Fernandes, H
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 2000, 9 (03) : 158 - 164
  • [3] Ahadi HR, 2022, IRAN J PUBLIC HEALTH, V51, P19, DOI 10.18502/ijph.v51i1.8288
  • [4] Allergies, genetic polymorphisms of Th2 interleukins, and childhood acute lymphoblastic leukemia: The ESTELLE study
    Ajrouche, Roula
    Chandab, Ghinaj
    Petit, Arnaud
    Strullu, Marion
    Nelken, Brigitte
    Plat, Genevieve
    Michel, Gerard
    Domenech, Carine
    Clavel, Jacqueline
    Bonaventure, Audrey
    [J]. PEDIATRIC BLOOD & CANCER, 2022, 69 (03)
  • [5] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
    Arber, Daniel A.
    Orazi, Attilio
    Hasserjian, Robert
    Thiele, Jurgen
    Borowitz, Michael J.
    Le Beau, Michelle M.
    Bloomfield, Clara D.
    Cazzola, Mario
    Vardiman, James W.
    [J]. BLOOD, 2016, 127 (20) : 2391 - 2405
  • [6] Interleukin-10-1082 G/A gene polymorphisms in Egyptian children with CAP: A case-control study
    Azab, Seham F.
    Abdalhady, Mohamed A.
    Elsaadany, Hosam F.
    Elkomi, Mohamed A.
    Elhindawy, Eman M.
    Sarhan, Dina T.
    Salam, Mohamed M. A.
    Allah, Mayy A. N.
    Emam, Ahmed A.
    Noah, Maha A.
    Abdelsalam, Nasser I.
    Abdellatif, Sawsan H.
    Rass, Anwar A.
    Ismail, Sanaa M.
    Gheith, Tarek
    Aziz, Khalid A.
    Hamed, Mohammed E.
    Abdelrahman, Hind M.
    Ahmed, Ahmed R.
    Nabil, Rehab M.
    Abdulmaksoud, Rehab S.
    Yousef, Hala Y.
    [J]. MEDICINE, 2016, 95 (26)
  • [7] Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia
    Banescu, Claudia
    Tripon, Florin
    Trifa, Adrian P.
    Crauciuc, Andrei G.
    Moldovan, Valeriu G.
    Boglis, Alina
    Benedek, Istvan
    Dima, Delia
    Candea, Marcela
    Duicu, Carmen
    Iancu, Mihaela
    [J]. CANCER MEDICINE, 2019, 8 (12): : 5492 - 5506
  • [8] Basturk B., INTERLOKIN 10 GEN PO
  • [9] Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias
    Bien, Ewa
    Balcerska, Anna
    Adamkiewicz-Drozynska, Elzbieta
    Rapala, Malgorzata
    Krawczyk, Malgorzata
    Stepinski, Jan
    [J]. CLINICAL BIOCHEMISTRY, 2009, 42 (10-11) : 1144 - 1157
  • [10] Genetic polymorphisms of Th2 interleukins, history of asthma or eczema and childhood acute lymphoid leukaemia: Findings from the ESCALE study (SFCE)
    Bonaventure, A.
    Orsi, L.
    Rudant, J.
    Goujon-Bellec, S.
    Leverger, G.
    Baruchel, A.
    Bertrand, Y.
    Nelken, B.
    Pasquet, M.
    Michel, G.
    Sirvent, N.
    Chastagner, P.
    Ducassou, S.
    Thomas, C.
    Besse, C.
    Hemon, D.
    Clavel, J.
    [J]. CANCER EPIDEMIOLOGY, 2018, 55 : 96 - 103